Efficacy and Tolerability of Novel A2A Agonist in Treatment of Diabetic Neuropathic Pain

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Swedish Orphan Biovitrum
ClinicalTrials.gov Identifier:
NCT00452777
First received: March 26, 2007
Last updated: October 31, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2008
  Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)